Health Economics and Policy

At last, a unique and useful function for femtosecond laser systems has emerged.

Although baby boomers may be in a state of denial regarding their own aging, ophthalmologists know differently. In particular, four diseases of the ageing eye comprise a demographic and economic timebomb.

Gene therapy for ocular disease will soon be available. Stem cell therapies too. They may be able to cure the currently untreatable, but at what price? And will anyone pay it?

Five questions that must be answered on the causes and consequences of near-sightedness.

A stark picture of an overstretched, fragile service, often at odds with hospital management, is painted in a recent RCO report. What can be done?

Increasing accessibility through art

A new Lancet study highlights the accuracy of DL models for detecting and diagnosing corneal infections